CLINICAL PROJECT MANAGER II - ONCOLOGY

CLINICAL PROJECT MANAGER II – ONCOLOGY Sponsored dedicated, Remote – United States Overview As a Clinical Project Manager II, you will play a critical role in the operational leadership and execution of global oncology clinical trials. You will support a high‑performing sponsor‑dedicated team across multiple indications and phases, ensuring studies are conducted efficiently, compliantly, and within established timelines. Key Responsibilities Support and partner with Clinical Study Leads and cross‑functional study teams on global oncology trials Lead day‑to‑day study management activities across study startup, conduct, maintenance, and closeout Manage study timelines, deliverables, risks, and issue resolution Oversee external vendors, CROs, central laboratories, imaging vendors, and specialty providers Coordinate Clinical Trial Team (CTT) meetings and drive action item follow‑up Support study‑level planning, forecasting, and operational strategy execution Monitor study performance metrics and proactively identify areas requiring intervention Ensure inspection readiness and compliance with applicable regulations and sponsor requirements Collaborate with stakeholders across Clinical Operations, Data Management, Biostatistics, Medical Monitoring, Regulatory Affairs, Safety, Supply Chain, and Quality Contribute to study status reporting and executive‑level communications Support achievement of study milestones, enrollment targets, database locks, and study closeout activities Required Qualifications Bachelor's degree in a scientific, healthcare, or related field 3+ years of Clinical Project Management experience supporting global oncology clinical trials Experience managing studies across multiple countries and regions (North America, Europe, Asia‑Pacific, Latin America, or other global regions) Vendor management experience required Strong understanding of clinical trial operations and study lifecycle management Experience supporting Phase I, Phase II, Phase III, and/or Phase IV oncology studies Strong working knowledge of ICH‑GCP guidelines and clinical research regulations Proficiency with Microsoft Office Suite Ability to work effectively within global, cross‑functional matrix organizations Oncology Therapeutic Area Experience Solid Tumors Non‑Small Cell Lung Cancer (NSCLC) Small Cell Lung Cancer (SCLC) Breast Cancer Ovarian Cancer Cervical Cancer Endometrial Cancer Prostate Cancer Colorectal Cancer Pancreatic Cancer Gastric Cancer Esophageal Cancer Hepatocellular Carcinoma (HCC) Melanoma Renal Cell Carcinoma (RCC) Bladder Cancer Head and Neck Cancer Thyroid Cancer Sarcoma Gynecologic Malignancies Hematologic Malignancies Multiple Myeloma Acute Myeloid Leukemia (AML) Acute Lymphoblastic Leukemia (ALL) Chronic Lymphocytic Leukemia (CLL) Chronic Myeloid Leukemia (CML) Hodgkin Lymphoma Non‑Hodgkin Lymphoma Myelodysplastic Syndromes (MDS) Myeloproliferative Neoplasms (MPN) Preferred Qualifications Experience independently leading global oncology studies Experience supporting complex, multi‑regional Phase II and Phase III programs Experience with early‑phase oncology studies (Phase I/Ib) Experience with immuno‑oncology, targeted therapies, cell therapy, or hematologic malignancies Familiarity with CTMS, eTMF, IRT/RTSM, and clinical data review platforms Experience working in sponsor‑dedicated or FSP environments Key Skills & Competencies Strong project management and organizational skills Excellent communication and stakeholder management abilities Proven ability to manage multiple priorities in a fast‑paced environment Strong risk identification and mitigation capabilities Detail‑oriented with a focus on quality, compliance, and execution Strong collaboration skills across global teams and functions Ability to influence without direct authority and drive accountability across study teams Clinical Phase Experience We welcome candidates with experience supporting Phase I / First‑in‑Human Studies, Phase I/Ib Dose Escalation Studies, Phase II Proof‑of‑Concept Studies, Phase II/III Registrational Studies, Phase III Global Pivotal Trials, Phase IV and Post‑Marketing Studies. Experience supporting global, multi‑country oncology programs through multiple phases of development is highly preferred. Salary Range $120,000 – $135,000 Equal Opportunity Statement The Company is committed to compliance with the Americans with Disabilities Act, including the provision of reasonable accommodations, when appropriate, to assist employees or applicants to perform the essential functions of the job. #J-18808-Ljbffr 1001 Syneos Health, LLC